Cargando…
Quality of life in brain metastases radiation trials: a literature review
BACKGROUND: An estimated 20%–40% of cancer patients will develop brain metastases. Whole-brain radiotherapy (wbrt) is the standard treatment for patients with brain metastases. Although wbrt can reduce neurologic symptoms, the median survival following wbrt is between 3 and 6 months. Given this limi...
Autores principales: | Wong, J., Hird, A., Kirou–Mauro, A., Napolskikh, J., Chow, E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582512/ https://www.ncbi.nlm.nih.gov/pubmed/19008990 |
Ejemplares similares
-
Two cases of acrometastasis to the hands and review of the literature
por: Flynn, C. J., et al.
Publicado: (2008) -
Single Versus Multiple Fractions of Palliative Radiotherapy for Bone Metastases: A Randomized Clinical Trial in Iranian Patients
por: Amouzegar–Hashemi, F., et al.
Publicado: (2008) -
Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma
por: Lafay–Cousin, L., et al.
Publicado: (2009) -
Research and Regulatory Issues for Integrative Oncology
por: Sagar, S.M., et al.
Publicado: (2008) -
The healing journey: incorporating psychological and spiritual dimensions into the care of cancer patients
por: Cunningham, A.J.
Publicado: (2008)